CATALYST PHARMACEUTICALS, INC. (CPRX)
Pharmaceutical Preparations
Latest Price
$31.49
TTM P/E
18.20
Normalized P/E
29.56
Div Yield
--
Book Value
8.28
P/B Ratio
3.80
Valuation metrics
adjust assumptions →EPS: $1.68
Book value / share: $7.79
Formula: √(22.5 × EPS × BVPS)
Graham Number
$17.16
46% downside
Norm. op. income: $87M (median of 7yr)
Tax rate: 24%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$11.15
65% downside
Base FCF: $143M (median of recent 5yr)
Growth: 25%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$92.88
+195% upside
EPS: $1.68
Target P/E: 30×
Formula: EPS × P/E
P/E Fair Value
$50.40
+60% upside
Institutional Ownership
87.7% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 19.16M | $602.0M | 15.68% | +384.3K | 2026-06-30 |
| STATE STREET CORP | 7.63M | $239.0M | 6.24% | +764.0K | 2026-06-30 |
| AMERICAN CENTURY COMPANIES INC | 5.55M | $174.0M | 4.55% | +1.42M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.14M | $161.0M | 4.20% | +12.7K | 2026-06-30 |
| DIMENSIONAL FUND ADVISORS LP | 3.63M | $114.0M | 2.97% | +204.6K | 2026-06-30 |
| GLAZER CAPITAL, LLC | 3.60M | $113.0M | 2.95% | -- | 2026-06-30 |
| JPMORGAN CHASE & CO | 3.17M | $99.0M | 2.59% | +2.80M | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.15M | $99.0M | 2.58% | +177.9K | 2026-06-30 |
| HBK INVESTMENTS L P | 2.82M | $88.0M | 2.31% | -- | 2026-06-30 |
| MORGAN STANLEY | 2.76M | $86.0M | 2.26% | +73.1K | 2026-06-30 |